Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 280

1.

Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research.

Di Minno A, Spadarella G, Prisco D, Scalera A, Ricciardi E, Di Minno G.

Blood Rev. 2015 Mar 31. pii: S0268-960X(15)00027-2. doi: 10.1016/j.blre.2015.03.004. [Epub ahead of print]

PMID:
25866382
2.

Periprocedural management of antithrombotic therapy and open issues in cancer patients.

Cuomo A, Cascella M, Bifulco F, Marracino M, Di Minno G, Cerbone AM.

Minerva Anestesiol. 2015 Mar 24. [Epub ahead of print]

PMID:
25800709
3.

Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?

Prisco D, Cenci C, Silvestri E, Ciucciarelli L, Di Minno G.

J Cardiovasc Med (Hagerstown). 2015 Mar 19. [Epub ahead of print]

PMID:
25798903
4.

Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies.

Di Minno MN, Ambrosino P, Ageno W, Rosendaal F, Di Minno G, Dentali F.

Thromb Res. 2015 May;135(5):923-32. doi: 10.1016/j.thromres.2015.03.010. Epub 2015 Mar 13.

PMID:
25784135
5.

Acquired hemophilia a successfully treated with rituximab.

D'Arena G, Grandone E, Di Minno MN, Musto P, Di Minno G.

Mediterr J Hematol Infect Dis. 2015 Mar 1;7(1):e2015024. doi: 10.4084/MJHID.2015.024. eCollection 2015.

6.

Thromboprophylaxis with low-molecular-weight heparins: an assessment of the methodological quality of studies.

Agnelli G, Prandoni P, Di Minno G, Cimminiello C, Scaglione F, Boracchi P, Molteni M, Polo Friz H, Di Minno MN, Marano G.

Semin Thromb Hemost. 2015 Mar;41(2):113-32. doi: 10.1055/s-0035-1544228. Epub 2015 Feb 17.

PMID:
25703242
7.

Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible?

Di Capua M, Livia Burzo M, Di Palo M, Marino A, Di Lorenzo G, Mesolella M, Mormile R, Di Minno G, Cerbone AM.

Haemophilia. 2014 Nov;20(6):e438-40. doi: 10.1111/hae.12552. No abstract available.

PMID:
25354776
8.

Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity: the REPOSI data.

Di Minno G.

Intern Emerg Med. 2015 Mar;10(2):251-2. doi: 10.1007/s11739-014-1103-6. Epub 2014 Oct 11. No abstract available.

PMID:
25304647
9.

Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis.

Ageno W, Di Minno MN, Ay C, Jang MJ, Hansen JB, Steffen LM, Vayà A, Rattazzi M, Pabinger I, Oh D, Di Minno G, Braekkan SK, Cushman M, Bonet E, Pauletto P, Squizzato A, Dentali F.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2478-85. doi: 10.1161/ATVBAHA.114.304085. Epub 2014 Sep 11.

PMID:
25212233
10.

Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.

Di Minno G, Spadarella G, Cafaro G, Petitto M, Lupoli R, Di Minno A, de Gaetano G, Tremoli E.

Ann Med. 2014 Nov;46(7):475-89. doi: 10.3109/07853890.2014.932618. Epub 2014 Jul 21.

11.

Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.

Di Capua M, Coppola A, Nardo A, Cimino E, Di Minno MN, Tufano A, Mormile R, Burzo ML, Di Minno G, Cerbone AM.

Blood Transfus. 2015 Apr;13(2):328-32. doi: 10.2450/2014.0047-14. Epub 2014 Jun 19. No abstract available.

12.

Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.

Calizzani G, Menichini I, Candura F, Lanzoni M, Profili S, Tamburrini MR, Fortino A, Vaglio S, Marano G, Facco G, Oliovecchio E, Franchini M, Coppola A, Arcieri R, Bon C, Saia M, Nuti S, Morfini M, Liumbruno GM, Di Minno G, Grazzini G.

Blood Transfus. 2014 Apr;12 Suppl 3:s582-8. doi: 10.2450/2014.0087-14s.

13.

Current and evolving features in the clinical management of haemophilia.

Coppola A, Morfini M, Cimino E, Tufano A, Cerbone AM, Di Minno G.

Blood Transfus. 2014 Apr;12 Suppl 3:s554-62. doi: 10.2450/2014.0043-14s. Review. No abstract available.

14.

Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis.

Dentali F, Di Minno MN, Turato S, Crestani S, Ambrosino P, Bonfanti C, Di Minno G, Ageno W, Franchini M.

Thromb Res. 2014 Aug;134(2):264-7. doi: 10.1016/j.thromres.2014.05.016. Epub 2014 May 15.

PMID:
24882273
15.

Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.

Morfini M, Batorova A, Mariani G, Auerswald G, Bernardi F, Di Minno G, Dolce A, Fede C, Giansily-Blaizot M, Ingerslev J, Martinowitz U, Napolitano M, Pinotti M, Schved JF; International FVII [IF7] and Seven Treatment Evaluation Registry [STER] Study Groups.

Thromb Haemost. 2014 Aug;112(2):424-5. doi: 10.1160/TH13-12-1045. Epub 2014 Apr 24. No abstract available.

PMID:
24763923
16.

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

Franchini M, Coppola A, Rocino A, Zanon E, Morfini M; Italian Association of Haemophilia Centers AICE Working Group, Accorsi A, Aru AB, Biasoli C, Cantori I, Castaman G, Cesaro S, Ciabatta C, De Cristofaro R, Delios G, Di Minno G, D'Incà M, Dragani A, Ettorre CP, Gagliano F, Gamba G, Gandini G, Giordano P, Giuffrida G, Gresele P, Latella C, Luciani M, Margaglione M, Marietta M, Mazzucconi MG, Messina M, Molinari AC, Notarangelo LD, Oliovecchio E, Peyvandi F, Piseddu G, Rossetti G, Rossi V, Santagostino E, Schiavoni M, Schinco P, Serino ML, Tagliaferri A, Testa S.

Haemophilia. 2014 Mar;20(2):e128-35. doi: 10.1111/hae.12334.

PMID:
24533954
17.

Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs).

Di Minno A, Spadarella G, Tufano A, Prisco D, Di Minno G.

Thromb Res. 2014 May;133(5):699-704. doi: 10.1016/j.thromres.2014.01.016. Epub 2014 Jan 18. Review.

PMID:
24525314
18.

Anticoagulant therapy in oncologic patients undergoing venous stenting for superior vena cava syndrome and other interventional procedures.

Iaccarino V, Venetucci P, Brunetti A, Ramundo V, Di Minno G.

Cardiovasc Intervent Radiol. 2014 Oct;37(5):1401-2. doi: 10.1007/s00270-013-0791-z. Epub 2014 Jan 25. No abstract available.

PMID:
24464255
19.

Clinical use of factor VIII and factor IX concentrates.

Morfini M, Coppola A, Franchini M, Di Minno G.

Blood Transfus. 2013 Sep;11 Suppl 4:s55-63. doi: 10.2450/2013.010s. Review. No abstract available.

20.

Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.

Coppola A, Tagliaferri A, Calizzani G, Candura F, Franchini M, Ruosi C, Grazzini G, Di Minno G.

Blood Transfus. 2013 Sep;11 Suppl 4:s101-9. doi: 10.2450/2013.016s. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk